FDS Stock Analysis: FactSet Research Systems | NYSE
Financial Data & Stock Exchanges | NYSE, USA | Market Cap: 8.946m USD | 12M Return: -45.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 237M
EPS Trend: 94.4%
Qual. Beats: 0
Rev. Trend: 99.8%
Qual. Beats: 5
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
FactSet Research Systems Inc. (NYSE: FDS) is a financial data and analytics platform serving the global investment community. The company provides subscription-based data, workstations, portfolio analytics, enterprise solutions, and managed services that support the investment lifecycle-from research and portfolio construction to trade execution, performance measurement, risk management, and reporting. Delivery channels include a configurable desktop and mobile platform, data feeds, cloud-based digital solutions, and application programming interfaces (APIs).
FactSet sells primarily to institutional clients, including asset managers, wealth managers, asset owners, bankers, hedge funds, and private equity and venture capital firms, generating recurring revenue through subscription contracts. The company operates across the Americas, Europe, the Middle East, Africa, and Asia Pacific, and was founded in 1978 with its headquarters in Norwalk, Connecticut.
FactSet operates within the GICS Financial Exchanges & Data sub-industry, competing alongside other providers of market data, analytics, and index services to investment professionals. Like peers in this segment, the business model is characterized by high recurring revenue tied to long-term client subscriptions, significant content and technology infrastructure requirements, and exposure to capital markets activity that influences client spending and seat counts.
- Subscription growth decelerates versus Bloomberg and S&P Capital IQ competition
- Operating margins pressured by rising data content and compensation costs
- Capital return program supports shareholder yield via dividends and buybacks
| Net Income: 566.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.17 > 0.02 and ΔFCF/TA 3.61 > 1.0 |
| NWC/Revenue: -13.83% < 20% (prev 10.56%; Δ -24.39% < -1%) |
| CFO/TA 0.20 > 3% & CFO 829.6m > Net Income 566.0m |
| Net Debt (1.45b) to EBITDA (690.7m): 2.10 < 3 |
| Current Ratio: 0.68 > 1.5 & < 3 |
| Outstanding Shares: last quarter (37.0m) vs 12m ago -3.90% < -2% |
| Gross Margin: 51.38% > 18% (prev 53.33%; Δ -1.95% > 0.5%) |
| Asset Turnover: 57.17% > 50% (prev 52.71%; Δ 4.46% > 0%) |
| Interest Coverage Ratio: 8.01 > 6 (EBIT TTM 640.1m / Interest Expense TTM 79.9m) |
| A: -0.08 (Total Current Assets 727.5m - Total Current Liabilities 1.06b) / Total Assets 4.19b |
| B: 0.62 (Retained Earnings 2.61b / Total Assets 4.19b) |
| C: 0.15 (EBIT TTM 640.1m / Avg Total Assets 4.27b) |
| D: 0.94 (Book Value of Equity 2.03b / Total Liabilities 2.16b) |
| Altman-Z'' = 3.50 = A |
| DSRI: 1.00 (Receivables 290.0m/271.9m, Revenue 2.44b/2.29b) |
| GMI: 1.04 (GM 53.33% / 51.38%) |
| AQI: 1.00 (AQ_t 0.78 / AQ_t-1 0.78) |
| SGI: 1.07 (Revenue 2.44b / 2.29b) |
| TATA: -0.06 (NI 566.0m - CFO 829.6m) / TA 4.19b) |
| Beneish M = -2.95 (Cap -4..+1) = A |
As of July 11, 2026, the stock is trading at USD 247.11 with a total of 529,959 shares traded. Over the past week, the price has changed by -1.49%, over one month by -1.69%, over three months by +13.84% and over the past year by -45.06%.
Current recommended Stop Loss: 222.90 (which is 9.8% or 1.9 ATR below the current price).
FactSet Research Systems has received a consensus analysts rating of 2.67. Therefore, it is recommended to hold FDS.
- StrongBuy: 2
- Buy: 0
- Hold: 12
- Sell: 3
- StrongSell: 4
| Analysts Target Price | 250.7 | 1.4% |
P/E Trailing = 15.8113
P/E Forward = 12.3457
P/S = 3.6476
P/B = 4.4018
P/EG = 1.1652
Revenue TTM = 2.44b USD
EBIT TTM = 640.1m USD
EBITDA TTM = 690.7m USD
Long Term Debt = 1.37b USD (from longTermDebt, last fiscal year)
Short Term Debt = 533.1m USD (from shortTermDebt, last quarter)
Debt = 1.76b USD (from shortLongTermDebtTotal, last quarter) + Leases 184.4m
Net Debt = 1.45b USD (calculated: Debt 1.76b - CCE 304.2m)
Enterprise Value = 10.4b USD (8.95b + Debt 1.76b - CCE 304.2m)
Interest Coverage Ratio = 8.01 (Ebit TTM 640.1m / Interest Expense TTM 79.9m)
EV/FCF = 14.68x (Enterprise Value 10.4b / FCF TTM 708.3m)
FCF Yield = 6.81% (FCF TTM 708.3m / Enterprise Value 10.4b)
FCF Margin = 29.05% (FCF TTM 708.3m / Revenue TTM 2.44b)
Net Margin = 23.21% (Net Income TTM 566.0m / Revenue TTM 2.44b)
Gross Margin = 51.38% ((Revenue TTM 2.44b - Cost of Revenue TTM 1.19b) / Revenue TTM)
Gross Margin QoQ = 49.88% (prev 51.43%)
Tobins Q-Ratio = 2.48 (Enterprise Value 10.4b / Total Assets 4.19b)
Interest Expense / Debt = 4.56% (Interest Expense 79.9m / Debt 1.76b)
Taxrate = 18.48% (128.3m / 694.3m)
NOPAT = 521.8m (EBIT 640.1m * (1 - 18.48%))
Current Ratio = 0.68 (Total Current Assets 727.5m / Total Current Liabilities 1.06b)
Debt / Equity = 0.86 (Debt 1.76b / totalStockholderEquity, last quarter 2.03b)
Debt / EBITDA = 2.10 (Net Debt 1.45b / EBITDA 690.7m)
Debt / FCF = 2.05 (Net Debt 1.45b / FCF TTM 708.3m)
Total Stockholder Equity = 2.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 13.27% (Net Income 566.0m / Total Assets 4.19b)
RoE = 26.58% (Net Income TTM 566.0m / Total Stockholder Equity 2.13b)
RoCE = 18.30% (EBIT 640.1m / Capital Employed (Equity 2.13b + L.T.Debt 1.37b))
RoIC = 14.75% (NOPAT 521.8m / Invested Capital 3.54b)
WACC = 6.89% (E(8.95b)/V(10.7b) * Re(7.51%) + D(1.76b)/V(10.7b) * Rd(4.56%) * (1-Tc(0.18)))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -98.88 | Cagr: -1.97%
[DCF] Terminal Value 77.97% ; FCFF base≈655.6m ; Y1≈751.5m ; Y5≈1.11b
[DCF] Fair Price = 417.0 (EV 16.6b - Net Debt 1.45b = Equity 15.2b / Shares 36.4m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 94.39 | EPS CAGR: 7.14% | SUE: 0.55 | # QB: 0
Revenue Correlation: 99.77 | Revenue CAGR: 5.63% | SUE: 1.15 | # QB: 5
EPS current Quarter (2026-11-30): EPS=4.89 | Chg30d=+0.49% | Revisions=-40% | Analysts=13
EPS current Year (2026-08-31): EPS=17.72 | Chg30d=+0.07% | Revisions=-25% | GrowthEPS=+4.3% | GrowthRev=+6.2%
EPS next Year (2027-08-31): EPS=19.54 | Chg30d=+0.78% | Revisions=-40% | GrowthEPS=+10.3% | GrowthRev=+5.7%
[Analyst] Revisions Ratio: -62% (up=0, down=5)